James Platt
Overview
Explore the profile of James Platt including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
176
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Appanna N, Mew R, Williams S, Starkey T, Patel G, Hudson L, et al.
Int J Cancer
. 2025 Mar;
PMID: 40062998
SARS-CoV-2 continues to spread across the world as a highly transmissible endemic disease. For many cancer patients, SARS-CoV-2 infection is unavoidable. It continues to disrupt cancer care, causing treatment delays...
2.
Fittall M, Liu J, Platt J, Ionescu M, Sheehan R, Johal S, et al.
Br J Cancer
. 2023 Apr;
128(11):1977-1980.
PMID: 37081188
The COVID-19 pandemic has led to a range of novel and adaptive research designs. In this perspective, we use our experience coordinating the National COVID Cancer Antibody Survey to demonstrate...
3.
Appanna N, Patel G, Burke E, Burnett A, Clark J, Mew R, et al.
Int J Cancer
. 2022 Dec;
152(6):1275-1277.
PMID: 36454180
No abstract available.
4.
Magill H, Ponugoti N, Selim A, Platt J
J Orthop Surg Res
. 2021 Jan;
16(1):78.
PMID: 33482862
Background: Periprosthetic fractures of the distal femur above a total knee arthroplasty (TKA) have traditionally been managed by locking compression plating (LCP). This technique is technically demanding and is associated...
5.
Lauer V, Grampp S, Platt J, Lafleur V, Lombardi O, Choudhry H, et al.
J Biol Chem
. 2019 Nov;
295(13):4065-4078.
PMID: 31690629
Hypoxia-inducible transcription factors (HIFs) directly dictate the expression of multiple RNA species including novel and as yet uncharacterized long noncoding transcripts with unknown function. We used pan-genomic HIF-binding and transcriptomic...
6.
Gershkovich P, Platt J, Knopf J, Tasoulis M, Shi W, Pusztai L, et al.
JCO Clin Cancer Inform
. 2019 Jan;
2:1-13.
PMID: 30652574
Purpose: Currently, there are only a few software tools designed to assist physicians to translate molecular abnormalities in the cancer genome into potential treatment options. There is a pressing need...
7.
Gayvert K, Aly O, Platt J, Bosenberg M, Stern D, Elemento O
PLoS Comput Biol
. 2017 Jan;
13(1):e1005308.
PMID: 28085880
A promising alternative to address the problem of acquired drug resistance is to rely on combination therapies. Identification of the right combinations is often accomplished through trial and error, a...
8.
Patel J, Knopf J, Reiner E, Bossuyt V, Epstein L, DiGiovanna M, et al.
Oncotarget
. 2016 Mar;
7(16):22064-76.
PMID: 26980737
Interpretation of complex cancer genome data, generated by tumor target profiling platforms, is key for the success of personalized cancer therapy. How to draw therapeutic conclusions from tumor profiling results...
9.
Park S, Platt J, Lee J, Lopez-Giraldez F, Herbst R, Koo J
J Natl Cancer Inst
. 2015 Jun;
107(9).
PMID: 26089541
Background: The E2F members have been divided into transcription activators (E2F1-E2F3) and repressors (E2F4-E2F8). E2F8 with E2F7 has been known to play an important physiologic role in embryonic development and...
10.
Copeland H, Pocewicz A, Naugle D, Griffiths T, Keinath D, Evans J, et al.
PLoS One
. 2013 Jul;
8(6):e67261.
PMID: 23826250
Increasing energy and housing demands are impacting wildlife populations throughout western North America. Greater sage-grouse (Centrocercus urophasianus), a species known for its sensitivity to landscape-scale disturbance, inhabits the same low...